Search

Search Constraints

You searched for: Author/Creator Argilés, Guillem

Search Results

1. A randomised phase 2 study comparing different dose approaches of induction treatment of regorafenib in previously treated metastatic colorectal cancer patients (REARRANGE trial). (December 2022)

2. Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial. Issue 6 (June 2019)

3. BRAF, MEK and EGFR inhibition as treatment strategies in BRAF V600E metastatic colorectal cancer. (February 2021)

6. Impact of circulating tumor DNA mutant allele fraction on prognosis in RAS‐mutant metastatic colorectal cancer. Issue 9 (31st July 2019)

7. Incorporating traditional and emerging biomarkers in the clinical management of metastatic colorectal cancer: an update. (2nd July 2020)

8. Incorporating traditional and emerging biomarkers in the clinical management of metastatic colorectal cancer: an update. (2nd July 2020)

9. Molecular Classification of Appendiceal Adenocarcinoma. Issue 8 (9th December 2022)

10. Phase I dose-escalation of trifluridine/tipiracil in combination with oxaliplatin in patients with metastatic colorectal cancer. (May 2019)